IMRX vs VRTX: Which Stock is Better?
Side-by-side comparison of Immuneering Corp and Vertex Pharmaceuticals Inc in 2026
IMRX
Immuneering Corp
$5.56
VRTX
Vertex Pharmaceuticals Inc
$441.20
Key Metrics Comparison
| Metric | IMRX | VRTX | Winner |
|---|---|---|---|
| Market Cap | $360.12M | $110.81B | VRTX |
| P/E Ratio | N/A | 28.42 | VRTX |
| EPS (TTM) | $N/A | $15.33 | VRTX |
| Revenue Growth | -1.0% | 0.1% | VRTX |
| Gross Margin | 34907.7% | 53.7% | IMRX |
Analyze IMRX
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMRX or VRTX a better investment?
Comparing IMRX and VRTX: Immuneering Corp has a market cap of $360.12M while Vertex Pharmaceuticals Inc has $110.81B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMRX and VRTX?
IMRX (Immuneering Corp) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMRX or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMRX or VRTX?
VRTX has higher revenue growth at 0.1% vs -1.0% for IMRX.
Which company is more profitable: IMRX or VRTX?
Immuneering Corp (IMRX) has higher gross margins at 34907.7% compared to 53.7% for VRTX.
Which is the larger company: IMRX or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $110.81B compared to $360.12M for IMRX.
Should I buy IMRX or VRTX in 2026?
Both IMRX and VRTX have investment merit. IMRX trades at $5.56 while VRTX trades at $441.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMRX and VRTX stock?
Key differences: Market Cap ($360.12M vs $110.81B), P/E Ratio (N/A vs 28.4x), Revenue Growth (-1.0% vs 0.1%), Gross Margin (34907.7% vs 53.7%).